Loading clinical trials...
Loading clinical trials...
The aim of the study is to assess the practical usability of EGFR mutation detection in ctDNA from early NSCLC.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Samsung Medical Center
Collaborators
NCT07489066 · Carcinoma, Non-Small-Cell Lung, and more
NCT07109154 · Lung Neoplasms
NCT07143110 · Lung Neoplasms
NCT06885697 · Mesothelioma, Neoplasms, and more
NCT04577599 · Lung Neoplasms, Lung Cancer
Samsung Medical Center
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions